Orchestra BioMed Holdings (OBIO) Intangibles (2021)

Orchestra BioMed Holdings' (OBIO) quarterly Intangibles came in at $5.0 million in Q3 2021.

Orchestra BioMed Holdings (OBIO) Intangibles (2021) Analysis & Trends

Orchestra BioMed Holdings (OBIO) has 1 years of Intangibles data on file, last reported at $5.0 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 16.97 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 11,640.44
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 61.68 Mn
4 NuCana 279.75 Bn 279.75 Bn - 2.92 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 418.50 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 1.29 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 266.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 55.80 Mn
10 Orchestra BioMed Holdings 228.31 Mn 143.68 Mn 78,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2021 5.00 Mn